Skip to Main Content

Paper Details

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients.
Transfusion
54
2005

Datasets

Release 1.2